Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled…

Overview of attention for article published in Lancet Infectious Diseases, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 7 news outlets
policy: 3 policy sources
twitter: 118 X users

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 258 Mendeley

So far, Altmetric has seen 3 policy documents that reference this research output.

U.S. Primary Care Physicians’ Viewpoints on HPV Vaccination for Adults 27–45 Years

Cited by Centers for Disease Control and Prevention (CDC) on 01 Jan 2021

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Medicinsk teknologivurdering (MTV) af HPV vaccination til drenge

Cited by Danish Health Authority on 29 Jun 2019

The Danish Health Authority advises municipalities and regions and comes up with recommendations, guidelines and action plans, to promote public health and create a good framework for the healthcare system in Denmark.

HPV vaccination: Background information for the Dutch Health Council

Cited by Rijksinstituut voor Volksgezondheid en Milieu on 16 May 2017

RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.